Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorEastern Mediterranean University

About this trial

This randomized controlled pretest-posttest experimental study aims to evaluate the effect of virtual reality (VR) on pain and anxiety levels experienced during Pap smear sampling. Although cervical cancer is largely preventable through regular screening, many women avoid Pap smear testing due to anxiety, fear of pain, and discomfort during gynecological examinations. Innovative, non-invasive interventions are needed to improve women's screening experiences and participation rates.

The study will be conducted in a gynecology outpatient clinic with 60 women aged 18-65 years who meet the inclusion criteria and provide informed consent. Participants will be randomly assigned to either the intervention group (VR headset during the procedure) or the control group (standard care). Women in the intervention group will watch a 360° relaxing nature video during the Pap smear procedure. Data will be collected using a Personal Information Form, the State Anxiety Inventory, and the Visual Analog Scale (VAS). The findings may support integrating VR into clinical practice to enhance patient comfort during screening procedures.

Eligibility criteria

Qualifiers

Women aged 18-65 years

Scheduled for a Pap smear procedure

Able to communicate in Turkish

Able to understand and complete the study questionnaires

Disqualifiers

History of severe motion sickness or vertigo

Diagnosed psychiatric disorder affecting anxiety assessment

Use of anxiolytic or sedative medication within 24 hours prior to the procedure

Presence of acute pelvic pain or active vaginal infection

Trial design

Treatments tested in this trial

  • Virtual Reality

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations